uniQure
Focus: uniQure is a Netherlands-based gene therapy specialist focused on rare genetic diseases including Huntington's, lysosomal storage disorders, and neurological conditions. The company operates as a pre-revenue or early-stage biotech with a pipeline of investigational AAV-based therapies.
Profile data last refreshed 9h ago · AI intelligence enriched 1w ago
Open Jobs
0
About uniQure
AI assessmentNot HiringNo open roles listed right now. Follow uniQure to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
11 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Qualitative interview
HemophiliaClinical Trials (1)
NCT04723680An Exploration of the Impact of Gene Therapy on the Lives of People With Haemophilia and Their Families
N/AHelp build intelligence for uniQure
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.